Medistem Laboratories, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Ichim Thomas, was filed 25 Mar 2008.
Medistem Laboratories, Inc.: what insiders have been doing
Medistem Laboratories, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). Medistem Laboratories, Inc. has had no insider filing for more than a year; the last one goes back to 19 November 2013.
Since 2006, the database holds 4 purchases and 7 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Financial data
as of FY 2013FY ended September 2013 · cache
- 900 shares@ US$1.42Common StockSEC:0001019687-13-004483:0
- 500 shares@ US$1.49Common StockSEC:0001019687-13-004483:1
- 1,037 shares@ US$1.50Common StockSEC:0001019687-13-004483:2
- 3,500 shares@ US$1.55Common StockSEC:0001019687-13-004483:3
- 500 shares@ US$1.45Common StockSEC:0001019687-13-004409:0
- 100 shares@ US$1.40Common StockSEC:0001019687-13-004409:1
- 1,463 shares@ US$1.41Common StockSEC:0001019687-13-004409:2
- 18,000 shares@ US$0.05COMMON STOCKSEC:0001393905-08-000057:0Canonical exit: 22 Jun 2008 (T+90)
- 45,000 shares@ US$0.0799COMMON STOCKSEC:0001354093-07-000007:0Canonical exit: 5 Mar 2007 (T+90)
- 250,000 shares0COMMON STOCKSEC:0001354093-07-000008:0
- 150,000 shares0COMMON STOCKSEC:0000313368-07-000005:0
- 150,000 shares0COMMON STOCKSEC:0000313368-07-000003:0
- 75,000 shares0COMMON STOCKSEC:0000313368-07-000002:0
- 75,000 shares0COMMON STOCKSEC:0000313368-07-000006:0
- 1,500,000 shares0COMMON STOCKSEC:0000313368-07-000004:0
- 50,000 shares@ US$0.07Medistem Common StockSEC:0001350441-06-000001:0Canonical exit: 5 Mar 2007 (T+90)
- 10,000 shares@ US$0.0799Medistem Common StockSEC:0001350441-06-000001:1Canonical exit: 5 Mar 2007 (T+90)
17 of 17 declarations
About Medistem Laboratories, Inc.
Medistem Laboratories, Inc. is a company focused on developing biopharmaceutical products. It aims to provide innovative solutions for the treatment of various diseases.
